Showing results (2341-2350 of 3,422) with videos related to

Sort By:
Pageof 343
Eclinicalmedicine|February 9, 2026
The sensitivity of patient-reported outcome measures in surgical and non-surgical care: a systematic review and meta-epidemiological evaluation of randomised controlled trialsMikko Uimonen, Matias Vaajala, Antti Saarinen, et al.
Eclinicalmedicine|February 5, 2026
Preoperative ultrasound before sentinel lymph node biopsy in melanoma in the era of neoadjuvant treatment: a systematic review and meta-analysis of diagnostic performance and cost analysisJulia A van den Broek, Antonius W Schurink, Brenda Leeneman, et al.
Eclinicalmedicine|February 9, 2026
Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 studyUzma N Sarwar, Jeffrey B Baker, Lisa Pereira, et al.
Eclinicalmedicine|February 2, 2026
Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trialWencheng Zhang, Tian Zhang, Xi Chen, et al.
Eclinicalmedicine|July 31, 2025
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulationCristina Mussini, Andrea Giacomelli, Eugenia Quiros-Roldan, et al.
Eclinicalmedicine|June 26, 2025
Identification and validation of an explainable early-stage chronic kidney disease prediction model: a multicenter retrospective studyJiayi He, Xin Wang, Peiqi Zhu, et al.
Eclinicalmedicine|June 16, 2025
The EORTC QLQ-F17 as a shortened version of the EORTC QLQ-C30 to assess self-reported functioning in cancer patients: investigating equivalence and psychometric properties in a randomized cross-over trialFlorian Zeman, Johannes M Giesinger, Tobias Pukrop, et al.
Eclinicalmedicine|June 17, 2025
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trialJhingook Kim, Yeong Hak Bang, Sehhoon Park, et al.
Eclinicalmedicine|June 17, 2025
Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis: a multi-biobank case-control studyJames Brogan, Ashwin Kishtagari, Robert W Corty, et al.
Eclinicalmedicine|June 16, 2025
No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysisEvangelia Antoniou, Annika Puschnig, Naghmeh Niktoreh, et al.
Pageof 343